search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Virtual reality imagery rescripting in PTSD patients: A proof of concept pilot study


- candidate number28583
- NTR NumberNTR7029
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR16-feb-2018
- Secondary IDs2018-CP-8752 
- Public TitleVirtual reality imagery rescripting in PTSD patients: A proof of concept pilot study
- Scientific TitleVirtual reality imagery rescripting in PTSD patients: A proof of concept pilot study
- ACRONYM
- hypothesis
- Healt Condition(s) or Problem(s) studiedPost-Traumatic Stress Disorder (PTSD), Virtual Reality
- Inclusion criteria- Primary diagnosis of PTSD, as established with a structured diagnostic interview (MINI, SCID, or CAPS).
- Index trauma is childhood (<16) sexual abuse.
- Conventional ImRs should be an appropriate treatment if patients were treated outside of the study. - 16 years or older.
- Sufficient fluency in Dutch to complete research procedures (informed consent and study measures).
- Willingness to provide written informed consent.
- Exclusion criteria- Other psychopathology that requires immediate other treatment or that would hinder study participation.
- mec approval receivedno
- multicenter trialno
- randomisedyes
- masking/blindingSingle
- controlActive
- groupCrossover
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-mrt-2018
- planned closingdate1-sep-2018
- Target number of participants6
- Interventions(1) Imagery Rescripting (active control treatment)
(2) Virtual Reality Imagery Rescripting (experimental treatment)
- Primary outcomePTSD Checklist for DSM-5 (PCL-5)
- Secondary outcomeHospital Anxiety and Depression Scale (HADS)
Post-Traumatic Cognitions Inventory (PTCI)
Non-fear emotion (e.g., guilt, anger, shame) items (added to PCL-5)
- TimepointsPrimary outcome (PCL-5) is administered weekly troughout the study.
Secondary outcomes are administered at every study phase change.
Presence of PTSD is assessed at the start (when evaluating the in-/exclusion criteria) and end of the study.
- Trial web site
- statusplanned
- CONTACT FOR PUBLIC QUERIESPhD A.A.P. Emmerik, van
- CONTACT for SCIENTIFIC QUERIESPhD A.A.P. Emmerik, van
- Sponsor/Initiator University of Amsterdam (UvA), Department of Clinical Psychology , PsyQ Purmerend, Technische Universiteit Delft
- Funding
(Source(s) of Monetary or Material Support)
- Publications
- Brief summary
- Main changes (audit trail)
- RECORD16-feb-2018 - 8-mrt-2018


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl